Biogen Alzheimer’s Drug Far From Done Deal, Wall Street Says

(Bloomberg) -- Nobody saw it coming. Biogen Inc. stunned investors with its surprise Alzheimer’s drug submission on Tuesday, reviving hopes for an experimental medicine that investors had mostly le...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.